CN Stock MarketDetailed Quotes

300485 Beijing Science Sun Pharmaceutical

Watchlist
  • 6.44
  • -0.04-0.62%
Market Closed Jun 14 15:00 CST
3.10BMarket Cap-35000P/E (TTM)

Beijing Science Sun Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
-38.48%126.24M
-46.88%120.16M
68.65%201.67M
91.18%217.46M
-10.64%205.2M
40.03%226.21M
-69.72%119.58M
-72.03%113.75M
-37.71%229.64M
-75.98%161.54M
Transactional financial assets
19.56%1.1B
17.65%1.05B
-23.15%890.08M
-24.97%854.63M
-12.13%921.14M
-21.08%895.39M
35.13%1.16B
47.15%1.14B
35.75%1.05B
123.48%1.13B
Notes receivable and accounts receivable
-33.41%52.91M
-38.16%52.42M
-30.52%68.08M
-21.98%67.93M
-11.30%79.46M
-11.88%84.76M
-4.44%97.98M
-27.30%87.07M
-24.21%89.59M
-25.53%96.19M
-Notes receivable
-57.00%4.4M
-37.76%5.46M
-27.89%6.19M
27.78%6.68M
115.14%10.23M
75.48%8.78M
1,048.58%8.58M
-65.84%5.23M
-68.79%4.75M
-64.15%5M
-Accounts receivable
-29.93%48.52M
-38.21%46.95M
-30.77%61.89M
-25.15%61.25M
-18.39%69.23M
-16.68%75.98M
-12.17%89.4M
-21.65%81.84M
-17.62%84.83M
-20.85%91.19M
Other receivables (including interest and dividends)
4.34%4.52M
-1.60%4.01M
180.57%4.22M
1.70%4.17M
-11.12%4.33M
315.67%4.08M
-2.69%1.5M
295.59%4.1M
253.62%4.87M
2.96%981.61K
-Other receivable
----
----
----
1.70%4.17M
----
315.67%4.08M
----
295.59%4.1M
----
2.96%981.61K
Advance payment
-97.53%115.25K
41.08%5.35M
297.62%4.61M
211.54%4.5M
74.70%4.66M
275.34%3.79M
-70.01%1.16M
51.84%1.44M
25.14%2.67M
101.80%1.01M
Inventories
11.29%108.46M
20.17%107.06M
27.03%108.47M
-0.96%99.22M
-11.25%97.46M
-27.60%89.09M
-38.36%85.39M
-34.62%100.17M
-35.37%109.81M
-22.43%123.05M
Other current assets
-52.21%8.06M
-37.81%10.65M
1,018.07%8.12M
194.91%8.52M
72.15%16.86M
33.50%17.12M
-82.22%726.15K
-68.16%2.89M
-41.18%9.79M
-8.52%12.83M
Total current assets
5.45%1.4B
2.47%1.35B
-12.24%1.29B
-13.26%1.26B
-11.08%1.33B
-13.71%1.32B
-2.54%1.46B
-1.12%1.45B
3.14%1.49B
3.15%1.53B
Non Current assets
Other non-current financial assets
-14.06%482.98M
10.91%631.81M
29.98%744.74M
39.07%786.82M
23.05%561.97M
46.00%569.67M
138.28%572.96M
147.40%565.76M
87.48%456.68M
101.55%390.18M
Long-term equity investment
-14.28%702.52M
-3.22%802.91M
21.07%833.61M
29.01%892.82M
28.15%819.54M
33.38%829.62M
49.48%688.52M
47.87%692.08M
35.95%639.5M
40.83%621.98M
Fixed assets
----
----
----
-7.86%537.86M
----
5.99%559.46M
----
7.10%583.72M
----
-5.98%527.84M
Constru in process
----
----
----
--482.24K
----
-99.54%327.52K
----
----
----
21.90%71.06M
Productive biological assets
--6.15M
--5.53M
--5.71M
--5.81M
----
----
----
----
----
----
Intangible assets
-7.24%48.91M
-7.12%49.95M
-7.95%50.89M
-8.26%51.68M
-8.13%52.72M
-7.98%53.78M
8.51%55.28M
3.60%56.34M
-0.67%57.39M
-4.51%58.44M
Development expenditure
12.33%209.4M
13.53%208.97M
14.16%202M
17.64%194.51M
15.69%186.42M
16.12%184.07M
16.31%176.95M
8.71%165.34M
8.18%161.13M
8.67%158.53M
Goodwill
0.00%21.87M
0.00%21.87M
0.00%21.87M
0.00%21.87M
0.00%21.87M
0.00%21.87M
0.00%21.87M
0.00%21.87M
0.00%21.87M
0.00%21.87M
Long deferred expense
----
----
----
----
----
--0
----
----
----
-97.40%27.8K
Deferred tax assets
-44.81%2.52M
-54.52%2.42M
108.12%5.27M
112.89%5.38M
76.75%4.57M
111.61%5.33M
-8.73%2.53M
5.81%2.53M
9.08%2.58M
-9.22%2.52M
Usufruct assets
-2.85%11.96M
-2.83%12.04M
--12.13M
--12.22M
--12.31M
--12.4M
----
----
----
----
Other non current assets
4.18%11.45M
-2.75%11.79M
-20.00%11.49M
4.56%11.56M
-80.50%10.99M
-36.23%12.12M
3.86%14.36M
-51.27%11.06M
230.51%56.38M
-4.14%19.01M
Total non current assets
-9.50%2.01B
0.91%2.27B
14.85%2.42B
20.12%2.52B
11.99%2.22B
20.15%2.25B
36.15%2.11B
34.41%2.1B
25.85%1.98B
24.14%1.87B
Total assets
-3.90%3.41B
1.49%3.62B
3.74%3.7B
6.49%3.78B
2.07%3.55B
4.92%3.57B
17.09%3.57B
17.21%3.55B
14.97%3.48B
13.73%3.4B
Liabilities
Current liabilities
Notes payable and accounts payable
-23.32%16.37M
-29.97%15.13M
-59.61%10.42M
-56.78%11.42M
26.01%21.35M
-21.21%21.61M
14.92%25.79M
-1.03%26.42M
-35.92%16.94M
-2.91%27.42M
-Accounts payable
-23.32%16.37M
-29.97%15.13M
-59.61%10.42M
-56.78%11.42M
26.01%21.35M
-21.21%21.61M
14.92%25.79M
-1.03%26.42M
-35.92%16.94M
-2.91%27.42M
Contract liabilities
-40.14%5.12M
-30.65%6.08M
-23.17%6.48M
-45.43%5.59M
-26.21%8.56M
-28.67%8.77M
10.64%8.43M
5.57%10.24M
45.39%11.6M
13.56%12.3M
Advance receipts
----
0.00%352.29K
----
----
----
28.00%352.29K
--0
----
----
0.00%275.23K
Salaries payable
-14.60%4.92M
-8.65%4.76M
16.31%5.29M
23.42%5.5M
19.19%5.76M
-14.08%5.21M
-2.90%4.55M
-23.50%4.46M
4.47%4.83M
-10.40%6.06M
Taxs payable
-22.21%2.64M
-58.94%1.34M
-78.74%1.84M
-32.53%3.07M
-50.01%3.4M
-54.35%3.27M
-14.87%8.68M
-33.97%4.55M
-6.96%6.8M
-18.33%7.17M
Other payable (including interest and dividends)
143.52%37.42M
-33.52%22.99M
-5.05%13.53M
89.21%22.48M
180.48%15.37M
2.00%34.59M
-68.41%14.25M
-82.95%11.88M
-93.08%5.48M
-57.30%33.91M
-Other payable
----
----
----
89.21%22.48M
----
2.00%34.59M
----
-82.95%11.88M
----
-57.30%33.91M
Non current liabilities due within one year
----
----
----
----
----
--0
----
----
----
----
Other current liabilities
-40.14%665.87K
-30.65%790.65K
-23.17%842.46K
-45.43%726.36K
-26.21%1.11M
-14.26%1.14M
10.64%1.1M
5.57%1.33M
45.39%1.51M
-5.53%1.33M
Total current liabilities
20.88%67.14M
-31.34%51.45M
-38.84%38.4M
-17.15%48.78M
17.79%55.54M
-15.29%74.94M
-31.02%62.8M
-50.96%58.88M
-62.73%47.15M
-34.81%88.46M
Current liabilities
Deferred tax liabilities
-16.46%67.81M
25.56%103.16M
96.50%100.87M
108.21%107.22M
99.68%81.16M
173.12%82.16M
613.50%51.33M
800.70%51.5M
772.03%40.65M
454.64%30.08M
Total non current liabilities
-16.46%67.81M
25.56%103.16M
96.50%100.87M
108.21%107.22M
99.68%81.16M
173.12%82.16M
613.50%51.33M
800.70%51.5M
772.03%40.65M
454.64%30.08M
Total liabilities
-1.29%134.94M
-1.58%154.61M
22.03%139.27M
41.34%156M
55.70%136.7M
32.52%157.1M
16.18%114.13M
-12.25%110.38M
-33.06%87.8M
-16.00%118.54M
Shareholders equity
Paid-in capital
0.00%481.67M
0.00%481.67M
0.00%481.67M
0.00%481.67M
0.00%481.67M
0.00%481.67M
0.00%481.67M
0.00%481.67M
0.00%481.67M
0.00%481.67M
Capital reserve funds
0.00%845.93M
0.00%845.93M
0.28%845.93M
0.28%845.93M
0.28%845.93M
0.28%845.93M
0.63%843.56M
0.63%843.56M
0.63%843.56M
0.63%843.56M
Surplus reserve funds
0.00%244.68M
0.00%244.68M
9.74%244.68M
9.74%244.68M
9.74%244.68M
9.74%244.68M
27.53%222.96M
27.53%222.96M
27.53%222.96M
27.53%222.96M
Retained profit
-7.21%1.67B
3.42%1.86B
4.57%1.96B
8.59%2.01B
-0.20%1.8B
6.01%1.8B
31.95%1.87B
35.66%1.85B
33.37%1.81B
29.56%1.7B
Other composite income
803.34%978.73K
181.85%917.04K
40.38%1.4M
273.69%1.63M
94.95%-139.16K
112.43%325.37K
148.30%999.33K
57.17%-940.3K
-67.98%-2.75M
-39.83%-2.62M
Shareholders equity without minority interests
-3.82%3.25B
1.84%3.44B
3.22%3.53B
5.46%3.59B
0.69%3.37B
3.98%3.37B
17.50%3.42B
18.95%3.4B
17.71%3.35B
15.70%3.24B
Minority interests
-20.76%29.85M
-17.09%31.58M
-4.52%34.85M
-2.84%35.97M
0.07%37.67M
-0.74%38.09M
-10.43%36.5M
-12.45%37.02M
-17.78%37.64M
-15.68%38.37M
Total shareholder equity
-4.00%3.28B
1.63%3.47B
3.13%3.56B
5.37%3.62B
0.68%3.41B
3.93%3.41B
17.12%3.46B
18.49%3.44B
17.14%3.39B
15.20%3.28B
Total liabilityies and equity
-3.90%3.41B
1.49%3.62B
3.74%3.7B
6.49%3.78B
2.07%3.55B
4.92%3.57B
17.09%3.57B
17.21%3.55B
14.97%3.48B
13.73%3.4B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds -38.48%126.24M-46.88%120.16M68.65%201.67M91.18%217.46M-10.64%205.2M40.03%226.21M-69.72%119.58M-72.03%113.75M-37.71%229.64M-75.98%161.54M
Transactional financial assets 19.56%1.1B17.65%1.05B-23.15%890.08M-24.97%854.63M-12.13%921.14M-21.08%895.39M35.13%1.16B47.15%1.14B35.75%1.05B123.48%1.13B
Notes receivable and accounts receivable -33.41%52.91M-38.16%52.42M-30.52%68.08M-21.98%67.93M-11.30%79.46M-11.88%84.76M-4.44%97.98M-27.30%87.07M-24.21%89.59M-25.53%96.19M
-Notes receivable -57.00%4.4M-37.76%5.46M-27.89%6.19M27.78%6.68M115.14%10.23M75.48%8.78M1,048.58%8.58M-65.84%5.23M-68.79%4.75M-64.15%5M
-Accounts receivable -29.93%48.52M-38.21%46.95M-30.77%61.89M-25.15%61.25M-18.39%69.23M-16.68%75.98M-12.17%89.4M-21.65%81.84M-17.62%84.83M-20.85%91.19M
Other receivables (including interest and dividends) 4.34%4.52M-1.60%4.01M180.57%4.22M1.70%4.17M-11.12%4.33M315.67%4.08M-2.69%1.5M295.59%4.1M253.62%4.87M2.96%981.61K
-Other receivable ------------1.70%4.17M----315.67%4.08M----295.59%4.1M----2.96%981.61K
Advance payment -97.53%115.25K41.08%5.35M297.62%4.61M211.54%4.5M74.70%4.66M275.34%3.79M-70.01%1.16M51.84%1.44M25.14%2.67M101.80%1.01M
Inventories 11.29%108.46M20.17%107.06M27.03%108.47M-0.96%99.22M-11.25%97.46M-27.60%89.09M-38.36%85.39M-34.62%100.17M-35.37%109.81M-22.43%123.05M
Other current assets -52.21%8.06M-37.81%10.65M1,018.07%8.12M194.91%8.52M72.15%16.86M33.50%17.12M-82.22%726.15K-68.16%2.89M-41.18%9.79M-8.52%12.83M
Total current assets 5.45%1.4B2.47%1.35B-12.24%1.29B-13.26%1.26B-11.08%1.33B-13.71%1.32B-2.54%1.46B-1.12%1.45B3.14%1.49B3.15%1.53B
Non Current assets
Other non-current financial assets -14.06%482.98M10.91%631.81M29.98%744.74M39.07%786.82M23.05%561.97M46.00%569.67M138.28%572.96M147.40%565.76M87.48%456.68M101.55%390.18M
Long-term equity investment -14.28%702.52M-3.22%802.91M21.07%833.61M29.01%892.82M28.15%819.54M33.38%829.62M49.48%688.52M47.87%692.08M35.95%639.5M40.83%621.98M
Fixed assets -------------7.86%537.86M----5.99%559.46M----7.10%583.72M-----5.98%527.84M
Constru in process --------------482.24K-----99.54%327.52K------------21.90%71.06M
Productive biological assets --6.15M--5.53M--5.71M--5.81M------------------------
Intangible assets -7.24%48.91M-7.12%49.95M-7.95%50.89M-8.26%51.68M-8.13%52.72M-7.98%53.78M8.51%55.28M3.60%56.34M-0.67%57.39M-4.51%58.44M
Development expenditure 12.33%209.4M13.53%208.97M14.16%202M17.64%194.51M15.69%186.42M16.12%184.07M16.31%176.95M8.71%165.34M8.18%161.13M8.67%158.53M
Goodwill 0.00%21.87M0.00%21.87M0.00%21.87M0.00%21.87M0.00%21.87M0.00%21.87M0.00%21.87M0.00%21.87M0.00%21.87M0.00%21.87M
Long deferred expense ----------------------0-------------97.40%27.8K
Deferred tax assets -44.81%2.52M-54.52%2.42M108.12%5.27M112.89%5.38M76.75%4.57M111.61%5.33M-8.73%2.53M5.81%2.53M9.08%2.58M-9.22%2.52M
Usufruct assets -2.85%11.96M-2.83%12.04M--12.13M--12.22M--12.31M--12.4M----------------
Other non current assets 4.18%11.45M-2.75%11.79M-20.00%11.49M4.56%11.56M-80.50%10.99M-36.23%12.12M3.86%14.36M-51.27%11.06M230.51%56.38M-4.14%19.01M
Total non current assets -9.50%2.01B0.91%2.27B14.85%2.42B20.12%2.52B11.99%2.22B20.15%2.25B36.15%2.11B34.41%2.1B25.85%1.98B24.14%1.87B
Total assets -3.90%3.41B1.49%3.62B3.74%3.7B6.49%3.78B2.07%3.55B4.92%3.57B17.09%3.57B17.21%3.55B14.97%3.48B13.73%3.4B
Liabilities
Current liabilities
Notes payable and accounts payable -23.32%16.37M-29.97%15.13M-59.61%10.42M-56.78%11.42M26.01%21.35M-21.21%21.61M14.92%25.79M-1.03%26.42M-35.92%16.94M-2.91%27.42M
-Accounts payable -23.32%16.37M-29.97%15.13M-59.61%10.42M-56.78%11.42M26.01%21.35M-21.21%21.61M14.92%25.79M-1.03%26.42M-35.92%16.94M-2.91%27.42M
Contract liabilities -40.14%5.12M-30.65%6.08M-23.17%6.48M-45.43%5.59M-26.21%8.56M-28.67%8.77M10.64%8.43M5.57%10.24M45.39%11.6M13.56%12.3M
Advance receipts ----0.00%352.29K------------28.00%352.29K--0--------0.00%275.23K
Salaries payable -14.60%4.92M-8.65%4.76M16.31%5.29M23.42%5.5M19.19%5.76M-14.08%5.21M-2.90%4.55M-23.50%4.46M4.47%4.83M-10.40%6.06M
Taxs payable -22.21%2.64M-58.94%1.34M-78.74%1.84M-32.53%3.07M-50.01%3.4M-54.35%3.27M-14.87%8.68M-33.97%4.55M-6.96%6.8M-18.33%7.17M
Other payable (including interest and dividends) 143.52%37.42M-33.52%22.99M-5.05%13.53M89.21%22.48M180.48%15.37M2.00%34.59M-68.41%14.25M-82.95%11.88M-93.08%5.48M-57.30%33.91M
-Other payable ------------89.21%22.48M----2.00%34.59M-----82.95%11.88M-----57.30%33.91M
Non current liabilities due within one year ----------------------0----------------
Other current liabilities -40.14%665.87K-30.65%790.65K-23.17%842.46K-45.43%726.36K-26.21%1.11M-14.26%1.14M10.64%1.1M5.57%1.33M45.39%1.51M-5.53%1.33M
Total current liabilities 20.88%67.14M-31.34%51.45M-38.84%38.4M-17.15%48.78M17.79%55.54M-15.29%74.94M-31.02%62.8M-50.96%58.88M-62.73%47.15M-34.81%88.46M
Current liabilities
Deferred tax liabilities -16.46%67.81M25.56%103.16M96.50%100.87M108.21%107.22M99.68%81.16M173.12%82.16M613.50%51.33M800.70%51.5M772.03%40.65M454.64%30.08M
Total non current liabilities -16.46%67.81M25.56%103.16M96.50%100.87M108.21%107.22M99.68%81.16M173.12%82.16M613.50%51.33M800.70%51.5M772.03%40.65M454.64%30.08M
Total liabilities -1.29%134.94M-1.58%154.61M22.03%139.27M41.34%156M55.70%136.7M32.52%157.1M16.18%114.13M-12.25%110.38M-33.06%87.8M-16.00%118.54M
Shareholders equity
Paid-in capital 0.00%481.67M0.00%481.67M0.00%481.67M0.00%481.67M0.00%481.67M0.00%481.67M0.00%481.67M0.00%481.67M0.00%481.67M0.00%481.67M
Capital reserve funds 0.00%845.93M0.00%845.93M0.28%845.93M0.28%845.93M0.28%845.93M0.28%845.93M0.63%843.56M0.63%843.56M0.63%843.56M0.63%843.56M
Surplus reserve funds 0.00%244.68M0.00%244.68M9.74%244.68M9.74%244.68M9.74%244.68M9.74%244.68M27.53%222.96M27.53%222.96M27.53%222.96M27.53%222.96M
Retained profit -7.21%1.67B3.42%1.86B4.57%1.96B8.59%2.01B-0.20%1.8B6.01%1.8B31.95%1.87B35.66%1.85B33.37%1.81B29.56%1.7B
Other composite income 803.34%978.73K181.85%917.04K40.38%1.4M273.69%1.63M94.95%-139.16K112.43%325.37K148.30%999.33K57.17%-940.3K-67.98%-2.75M-39.83%-2.62M
Shareholders equity without minority interests -3.82%3.25B1.84%3.44B3.22%3.53B5.46%3.59B0.69%3.37B3.98%3.37B17.50%3.42B18.95%3.4B17.71%3.35B15.70%3.24B
Minority interests -20.76%29.85M-17.09%31.58M-4.52%34.85M-2.84%35.97M0.07%37.67M-0.74%38.09M-10.43%36.5M-12.45%37.02M-17.78%37.64M-15.68%38.37M
Total shareholder equity -4.00%3.28B1.63%3.47B3.13%3.56B5.37%3.62B0.68%3.41B3.93%3.41B17.12%3.46B18.49%3.44B17.14%3.39B15.20%3.28B
Total liabilityies and equity -3.90%3.41B1.49%3.62B3.74%3.7B6.49%3.78B2.07%3.55B4.92%3.57B17.09%3.57B17.21%3.55B14.97%3.48B13.73%3.4B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg